Clinical and Immunological Aspects of Sepsis in Children with Primary Immunodeficiencies (PID): A Retrospective Analysis in The Setting of The Tashkent City Children’s Clinic
DOI:
https://doi.org/10.51699/cajmns.v7i1.3056Keywords:
Sepsis, Primary Immunodeficiency, Children, Clinical Features, Immunological Disorders, Retrospective AnalysisAbstract
Sepsis continues to be one of the major morbidities and mortalities among paediatric patients, especially in children with a primary immunodeficiency (PID). These patients are characterised by high susceptibility to severe infections, atypical clinical manifestations, and high probability of rapid progression of disease due to congenital defects of the immune system. The current research intends to examine clinical and immunological characteristics of sepsis in children with PID in terms of retrospective data analysis of cases treated in the Tashkent City Children's Clinic. A retrospective study was performed through the medical records of children diagnosed with PID and sepsis within a fixed study period. Clinical data and laboratories, immunological parameters, causative pathogens, treatment methods and outcomes were assessed. The features of immune dysfunction, such as the defects in humoral and cellular immunity, and their correlation with the progression and severity of sepsis, were singled out. The review showed that children with PID tend to exhibit severe and frequent septic events, late diagnosis, and length of stay. The prevalent ones were the persistent leukopenia or lymphopenia, low levels of immunoglobulins, and the lack of an inflammatory response. Opponent pathogens and Gram-negative bacteria were often verified as causative agents. Despite the intensive antimicrobial and supportive treatment, the threat of complications and the adverse outcomes were still very great in comparison with immunocompetent children. These results demonstrate the need to undertake early identification of PID in the septic child, timely immunological evaluation, and adopt a personalised treatment plan. Awareness of diagnosis and optimal multidisciplinary care can help improve the prognosis and decrease mortality in the susceptible population of such patients.
References
Weiss S.L., Fitzgerald J.C., Pappachan J., et al. Global epidemiology of pediatric sepsis: a systematic review. The Lancet Child & Adolescent Health.
Notarangelo L.D., Bacchetta R., Casanova J.L., Su H.C. Human inborn errors of immunity: an expanding universe. Journal of Allergy and Clinical Immunology.
Brierley J., Peters M.J. Sepsis in children: recognition, management and outcomes. Pediatric Critical Care Medicine.
Boomer J.S., To K., Chang K.C., et al. Immunosuppression in patients who die of sepsis. Nature Reviews Immunology.
Oved J.H., Orange J.S., Notarangelo L.D. Sepsis as a presenting feature of inborn errors of immunity. Frontiers in Immunology.
Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Critical Care.
Antachopoulos C., Walsh T.J., Roilides E. Invasive fungal infections in immunocompromised children. Clinical Microbiology and Infection.
Weiss S.L., Peters M.J., Alhazzani W., et al. Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. The Lancet Child & Adolescent Health.
Picard C., Bobby Gaspar H., Al-Herz W., et al. International Union of Immunological Societies: classification of primary immunodeficiency disorders. Journal of Clinical Immunology.
Bousfiha A., Jeddane L., Picard C., et al. The 2022 update of IUIS phenotypical classification for primary immunodeficiencies. Journal of Clinical Immunology.
Rimmele T., Payen D., Cantaluppi V., et al. Immune cell dysfunctions in sepsis. Intensive Care Medicine.
Tacconelli E., Carrara E., Savoldi A., et al. Discovery, research, and development of new antibiotics: the WHO priority list. The Lancet Infectious Diseases.
van der Poll T., Shankar-Hari M., Wiersinga W.J. The immunology of sepsis. Nature Reviews Immunology.
Notarangelo L.D. Primary immunodeficiencies: from genetic diagnosis to clinical management. New England Journal of Medicine.
S. Nepesov, S. Firtina, F. D. Aygun, N. Burtenece, H. Cokugras, and Y. Camcioglu, “Diagnosis of primary immunodeficiency diseases in pediatric patients hospitalized for recurrent, severe, or unusual infections,” Allergologia et Immunopathologia, vol. 50, no. 4, pp. 50–56, 2022.
X. Zeng et al., “Approach to Diagnosing Primary Immunodeficiencies,” EMJ Allergy & Immunology, vol. 10, no. 1, pp. 109–114, 2025.
A. Duhaniuc, “Multidrug Resistant Bacteria in Immunocompromised Patients,” Perspectives in Infectious Diseases, 2024.
G. Bottari et al., Immunomodulation in Pediatric Sepsis: A Narrative Review, Journal of Clinical Medicine, vol. 14, no. 9, 2025.
R. Schober et al., Outcomes of Immunocompromised Children Hospitalized with Severe Sepsis, Clinical Microbiology and Infection, 2023.
